News Image

Protara Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update

Provided By GlobeNewswire

Last update: Aug 11, 2025

NEW YORK, Aug. 11, 2025 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced financial results for the second quarter ended June 30, 2025, and provided a business update.

Read more at globenewswire.com

PROTARA THERAPEUTIC INC

NASDAQ:TARA (9/23/2025, 8:15:10 PM)

After market: 3.69 +0.11 (+3.07%)

3.58

-0.09 (-2.45%)



Find more stocks in the Stock Screener

Follow ChartMill for more